The nation of Zimbabwe has rejected a substantial American health deal worth 367 million US dollars (£272m) over five years because of the United States' insistence on sensitive information.
This move was revealed following a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa felt the agreement was "lopsided".
An official spokesperson has since clarified that the United States was demanding access to health data for scientific study and profit but was not willing to guarantee the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had donated more than $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for more dialogue to reach a agreement acceptable to both sides so the country's vital HIV treatment initiative can continue.
Wider Context
Zimbabwe's decision follows a comparable case in Kenya, where a high court suspended a similar health funding agreement after legal challenges were raised about the safety of Kenyans' medical information.
After resuming office last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.
The agency had overseen aid for the American government, but Trump argued its spending was "wasteful" and his administration was seeking government-to-government deals to boost openness and accountability.
According to statements, 16 nations in Africa have so far signed these new health pacts, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this cooperation might have yielded significant advantages for Zimbabwean communities, especially the 1.2 million currently on antiretroviral therapy via US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana said the arrangement was "asymmetrical".
"Zimbabwe was being asked to provide its biological resources and data over an extended period, without any corresponding promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," Mangwana explained.
"Put simply, our nation would provide the raw materials for scientific discovery with no assurance that the resulting innovations would be available to our people if a future pandemic emerge."
National Interest and International Frameworks
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were upending systems previously set up via the international health agency.
Mangwana cited its Pandemic Benefit-Sharing framework designed to manage potential global health emergencies.
"This mechanism is designed to guarantee that when a nation contributes its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."
The government's concerns regarding the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We welcome continued discussions with our US partners on how subsequent collaboration might be structured in a way that honours the independence and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it acknowledged the government's concerns, but recommended that negotiations should continue considering much of the nation's Aids initiatives were funded by foreign aid.
"In cases where technical issues arise, such as those relating to information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," the group said.
The situation highlights the complex tensions between accepting vital foreign assistance and safeguarding national sovereignty in an ever more data-driven world.